Grifols, S.A Operating Income 2012-2019 | GRFS

Grifols, S.A annual/quarterly operating income history and growth rate from 2012 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Grifols, S.A operating income for the quarter ending June 30, 2019 was $0.356B, a 33.33% increase year-over-year.
  • Grifols, S.A operating income for the twelve months ending June 30, 2019 was $1.251B, a 20.35% increase year-over-year.
  • Grifols, S.A annual operating income for 2018 was $1.174B, a 3.53% increase from 2017.
  • Grifols, S.A annual operating income for 2017 was $1.134B, a 9.09% increase from 2016.
  • Grifols, S.A annual operating income for 2016 was $1.04B, a 3.52% decline from 2015.
Grifols, S.A Annual Operating Income
(Millions of US $)
2018 $1,174
2017 $1,134
2016 $1,040
2015 $1,077
2014 $1,140
2013 $978
2012 $849
2011 $450
Grifols, S.A Quarterly Operating Income
(Millions of US $)
Q2 2019 $356
Q2 2018 $312
Q2 2017 $314
Q1 2017 $269
Q4 2016 $267
Q3 2016 $267
Q2 2016 $250
Q1 2016 $255
Q4 2015 $276
Q3 2015 $275
Q2 2015 $259
Q1 2015 $264
Q4 2014 $171
Q3 2014 $284
Q2 2014 $237
Q1 2014 $324
Q4 2013 $209
Q3 2013 $247
Q2 2013 $266
Q1 2013 $248
Q4 2012 $188
Q3 2012 $215
Q2 2012 $216
Q1 2012 $213
Q4 2011 $796
Q3 2011 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $15.119B $5.299B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.871B 36.87
Astellas Pharma (ALPMY) Japan $26.681B 13.08
Takeda Pharmaceutical (TAK) Japan $26.123B 8.16
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.535B 24.99
Merck (MKGAF) Germany $13.648B 18.62
Ionis Pharmaceuticals (IONS) United States $9.706B 20.93
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.905B 0.00
IPSEN SA ADR (IPSEY) France $8.570B 0.00
Sage Therapeutics (SAGE) United States $8.368B 0.00
Catalent (CTLT) United States $8.137B 32.65
Jazz Pharmaceuticals (JAZZ) Ireland $7.634B 10.05
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.913B 17.66
FibroGen (FGEN) United States $3.876B 96.96
United Therapeutics (UTHR) United States $3.568B 0.00
Nektar Therapeutics (NKTR) United States $3.172B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.143B 11.27
Evotec AG (EVTCY) Germany $3.127B 42.81
Tilray (TLRY) Canada $3.044B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.957B 67.80
PTC Therapeutics (PTCT) United States $2.660B 0.00
Xencor (XNCR) United States $2.306B 50.28
Zogenix (ZGNX) United States $2.111B 0.00
Portola Pharmaceuticals (PTLA) United States $2.078B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.591B 57.91
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.500B 15.05
Corcept Therapeutics (CORT) United States $1.477B 20.30
Enanta Pharmaceuticals (ENTA) United States $1.416B 23.35
Ironwood Pharmaceuticals (IRWD) United States $1.372B 0.00
Heron Therapeutics (HRTX) United States $1.371B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.204B 0.00
ArQule (ARQL) United States $1.078B 0.00
Radius Health (RDUS) United States $1.066B 0.00
Aerie Pharmaceuticals (AERI) United States $1.065B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.904B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.724B 3.23
TherapeuticsMD (TXMD) United States $0.690B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.593B 0.00
Karyopharm Therapeutics (KPTI) United States $0.562B 0.00
Akebia Therapeutics (AKBA) United States $0.559B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.542B 0.00
Concordia (CXRXF) Canada $0.533B 0.00
Endo (ENDP) Ireland $0.512B 0.90
Indivior (INVVY) United States $0.487B 1.76
Aptorum Group (APM) China $0.472B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.453B 0.00
Dermira (DERM) United States $0.448B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.431B 19.58
ImmunoGen (IMGN) United States $0.424B 0.00
Siga Technologies (SIGA) United States $0.421B 0.98
Organogenesis Holdings (ORGO) United States $0.421B 0.00
Flexion Therapeutics (FLXN) United States $0.419B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Translate Bio (TBIO) United States $0.415B 0.00
ChemoCentryx (CCXI) United States $0.390B 0.00
Collegium Pharmaceutical (COLL) United States $0.386B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.325B 0.00
CV Sciences (CVSI) United States $0.317B 0.00
Xeris Pharmaceuticals (XERS) United States $0.313B 0.00
CannTrust Holdings (CTST) Canada $0.297B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.286B 0.00
Rafael Holdings (RFL) United States $0.285B 0.00
KalVista Pharmaceuticals (KALV) United States $0.285B 0.00
Harpoon Therapeutics (HARP) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.266B 2.58
La Jolla Pharmaceutical (LJPC) United States $0.265B 0.00
OptiNose (OPTN) United States $0.263B 0.00
DURECT (DRRX) United States $0.261B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.252B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
Recro Pharma (REPH) United States $0.242B 0.00
Calithera Biosciences (CALA) United States $0.216B 0.00
Ocular Therapeutix (OCUL) United States $0.211B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.189B 0.00
Molecular Templates (MTEM) United States $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 29.03
Taiwan Liposome (TLC) Taiwan $0.165B 0.00
IMV INC (IMV) Canada $0.157B 0.00
Ardelyx (ARDX) United States $0.155B 0.00
Redhill Biopharma (RDHL) Israel $0.151B 0.00
GlycoMimetics (GLYC) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.131B 0.00
Generex Biotechnology (GNBT) United States $0.128B 0.00
Majesco Entertainment (PTE) United States $0.121B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.117B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.114B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.112B 0.00
MEI Pharma (MEIP) United States $0.110B 0.00
AgeX Therapeutics (AGE) United States $0.108B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.105B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.091B 0.00
Cardiome Pharma (CORV) Canada $0.089B 0.00
Nivalis Therapeutics (ALPN) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 33.11
Genocea Biosciences (GNCA) United States $0.082B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.077B 0.00
Natural Alternatives (NAII) United States $0.075B 7.54
MediWound (MDWD) Israel $0.074B 0.00
Champions Oncology (CSBR) United States $0.072B 618.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Infinity Pharmaceuticals (INFI) United States $0.070B 0.00
Otonomy (OTIC) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Capnia (SLNO) United States $0.064B 0.00
Novan (NOVN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
Lipocine (LPCN) United States $0.058B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
CTI BioPharma (CTIC) United States $0.038B 0.00
Aclaris Therapeutics (ACRS) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Melinta Therapeutics (MLNT) United States $0.032B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.031B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
IsoRay (ISR) United States $0.022B 0.00
Opexa Therapeutics (ACER) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.41
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00